References
- Jones R, Latinovic R, Charlton J, et al. Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database. Bmj. 2007;334:1040–1048.
- Carel RS, Silverberg DS, Kaminsky R, et al. Routine urinalysis (dipstick) findings in mass screening of healthy adults . Clin Chem. 1987;33:2106–2108.
- Schroeder GL, Lorenzo-Gomez MF, Hautmann SH, et al. A side by side comparison of cytology and biomarkers for bladder cancer detection. J Urol. 2004;172:1123–1126.
- Bangma CH, Loeb S, Busstra M, et al. Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers. Eur Urol. 2013;64:41–47.
- Steiner H, Bergmeister M, Verdorfer I, et al. Early results of bladder-cancer screening in a high-risk population of heavy smokers. BJU Int. 2008;102:291–296.
- Pesch B, Nasterlack M, Eberle F, et al. The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines. BJU Int. 2011;108:546–552.
- Krogsbøll LT, Juhl Jørgensen K, Gøtzsche PC. Screening with urinary dipsticks for reducing morbidity and mortality. First published: 27 January 2015 Cochrane DOI: 10.1002/14651858.CD010007.pub2
- Ezz el Din K, Koch WF, de Wildt MJ, et al. The predictive value of microscopic haematuria in patients with lower urinary tract symptoms and benign prostatic hyperplasia. Eur Urol. 1996;30:409–413.
- Tan WS, Feber A, Sarpong R, et al. Who Should Be Investigated for Haematuria? Results of a Contemporary Prospective Observational Study of 3556 Patients. Eur Urol. 2018;74:10–14.
- Lotan Y, Editioral comment to Tan, et al. Re: Who Should be Investigated for Hematuria? Results of a Contemporary Prospective Observational Study of 3556 Patients. Eur Urol. 2018;74:15–16.
- Malmström PU. Time to abandon testing for microscopic haematuria in adults?. Bmj. 2003;326:813–815.
- Davis R, Jones JS, Barocas DA, et al. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol. 2012;188:2473–2481.
- Jefferies ER, Brewster SF. BAUS Section on Oncology. Urological recommendations from the National Institute for Health and Care Excellence (NICE) Guideline, June 2015: Suspected cancer: recognition and referral. BJU Int. 2016;117:857–860.
- Ugeskr Laeger. Urinary bladder tumors. Report of the Danish Bladder-cancer Committee 1993. 1997;159:1–14.
- Ordell Sundelin M, Jensen JB. Asymptomatic microscopic hematuria as a predictor of neoplasia in the urinary tract. Scand J Urol. 2017;51:373–375.
- Elmussareh M, Young M, Ordell Sundelin M, et al. Outcomes of haematuria referrals: two-year data from a single large university hospital in Denmark. Scand J Urol. 2017;51:282–289.
- Hansen E, Larsson H, Nørgaard M, et al. The Danish Bladder Cancer Database. Clin Epidemiol. 2016;8:439–443.
- Jahnson S, Hosseini Aliabad A, Holmäng S, et al. Swedish National Registry of Urinary Bladder Cancer: No difference in relative survival over time despite more aggressive treatment. Scand J Urol. 2016;50:14–20.
- Malmström PU, Liedberg F, Sherif A, et al. Is there finally an increasing survival of patients with urinary bladder cancer? A nationwide study in Sweden 1997–2016. European Urology Supplements 2018;17:858.
- Ramirez D, Gupta A, Canter D, et al. Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer. BJU Int. 2016;117:783–786.